首页> 外文OA文献 >Addition of 3-day aprepitant to ondansetron and dexamethasone for prophylaxis of chemotherapy-induced nausea and vomiting among patients with diffuse large B cell lymphoma receiving 5-day cisplatin-based chemotherapy

【2h】

Addition of 3-day aprepitant to ondansetron and dexamethasone for prophylaxis of chemotherapy-induced nausea and vomiting among patients with diffuse large B cell lymphoma receiving 5-day cisplatin-based chemotherapy

机译：在接受5天顺铂化疗的弥漫性大B细胞淋巴瘤患者中加用3天阿瑞吡坦治疗昂丹司琼和地塞米松预防化疗引起的恶心和呕吐

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Raafat Abdel-Malek; Noha Abbas; Kyrillus S. Shohdy; Mohamed Ismail; Radwa Fawzy; Dalal S. Salem; Ezzat Safwat;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Addition of 3-day aprepitant to ondansetron and dexamethasone for prophylaxis of chemotherapy-induced nausea and vomiting among patients with diffuse large B cell lymphoma receiving 5-day cisplatin-based chemotherapy [J] . Raafat Abdel-Malek, Noha Abbas, Kyrillus S. Shohdy, Journal of the Egyptian National Cancer Institute . 2017,第3期

机译：在恩丹西酮和地塞米松基础上加用3天的阿瑞匹坦预防5天以顺铂为基础的化疗的弥漫性大B细胞淋巴瘤患者化疗引起的恶心和呕吐
2. Addition of 3-day aprepitant to ondansetron and dexamethasone for prophylaxis of chemotherapy-induced nausea and vomiting among patients with diffuse large B cell lymphoma receiving 5-day cisplatin-based chemotherapy [J] . Raafat Abdel-Malek, Noha Abbas, Kyrillus S. Shohdy, Theoretical and Experimental Plant Physiology . 2017,第3期

机译：添加了3天的服用3天的ondansetron和地塞米松，用于预防化学疗法诱导的弥漫性大B细胞淋巴瘤患者的化疗诱导的恶心，促进5天顺铂基化疗
3. Randomized open-label phase II trial of 5-day aprepitant plus ondansetron compared to ondansetron alone in the prevention of chemotherapy-induced nausea-vomiting (CINV) in glioma patients receiving adjuvant temozolomide [J] . Mallika P. Patel, Sarah Woodring, Dina M. Randazzo, Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer . 2020,第5期

机译：随机开放标签期II试验5天的4. ondansetron与Ondansetron相比，单独在预防接受佐剂替斯替替莫唑胺的胶质瘤患者中预防化疗诱导的恶心呕吐（CINV）
4. Aprepitant for the Prevention of Acute Chemotherapy-induced Nausea and Vomiting in Children: Overcoming Barriers [D] . Patel, Priya 2018

机译：预防急性化疗引起的儿童恶心和呕吐的阿瑞品：克服障碍
5. Fosaprepitant versus aprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based chemotherapy: a multicenter randomized double-blind double-simulated positive-controlled phase III trial [O] . Zhonghan Zhang, Yunpeng Yang, Ping Lu, 2020

机译：Fosaprepitant与aprepitant预防以顺铂为基础的化疗患者化疗引起的恶心和呕吐：一项多中心随机双盲双模拟阳性对照的III期临床试验
6. Letter referencing “Randomized open-label phase II trial of 5-day aprepitant plus ondansetron compared to ondansetron alone in the prevention of chemotherapy-induced nausea-vomiting in glioma patients receiving adjuvant temozolomide” [O] . Kayoko Morio, Jun Watanabe, Yasushi Tsujimoto 2020

机译：信件引用“5天的随机开放标签期第二次试验与ondansetron相比，与ondansetron相比，单独在预防接受佐剂替斯替斯多洛族蛋白的胶质瘤患者中的化疗诱导的恶心呕吐”

Addition of 3-day aprepitant to ondansetron and dexamethasone for prophylaxis of chemotherapy-induced nausea and vomiting among patients with diffuse large B cell lymphoma receiving 5-day cisplatin-based chemotherapy

著录项

引文网络

相似文献

相关主题

期刊订阅